The Tumor Suppressor Gene TP53: Implications for Cancer Management and Therapy

Author： Seemann Séverine   Maurici Daniela   Olivier Magali   Fromentel Claude   Hainaut Pierre  

Publisher： Informa Healthcare

ISSN： 1040-8363

Source： Critical Reviews in Clinical Laboratory Sciences, Vol.41, Iss.5-6, 2004-09, pp. : 551-583

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Alteration of thep53Tumor Suppressor Gene in Prostate Cancer: Analytical Approaches and Clinical Implications

By  

Oncology Research and Treatment, Vol. 21, Iss. 2, 1998-05 ,pp. : 113-122

Karger

Access to resources Recommend Favorite

Chemoresistance of Cancer Cells: Oncogenic Mutation of the p53 Tumor Suppressor Gene

By  

Current Signal Transduction Therapy, Vol. 11, Iss. 1, 2016-04 ,pp. : 3-8

Bentham Science Publishers

Access to resources Recommend Favorite

Refined chromosomal localization of the putative tumor suppressor gene TP73

By  

Cytogenetic and Genome Research, Vol. 82, Iss. 3-4, 1998-12 ,pp. : 199-201

Karger

Access to resources Recommend Favorite

Clinical Application of Oligonucleotide Probe Array for Full-Length Gene Sequencing of TP53 in Colon Cancer

By  

Oncology, Vol. 64, Iss. 1, 2002-12 ,pp. : 54-60

Karger

Access to resources Recommend Favorite

Assignment of the tumor protein p53 induced nuclear protein 2 (TP53INP2) gene to human chromosome band 20q11.2 by in situ hybridization

By  

Cytogenetic and Genome Research, Vol. 108, Iss. 4, 2004-12 ,pp. : 362B-

Karger

Access to resources Recommend Favorite